Texas Permanent School Fund Corp Boosts Stock Holdings in Cardinal Health, Inc. $CAH

Texas Permanent School Fund Corp increased its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 16.8% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 30,508 shares of the company’s stock after buying an additional 4,384 shares during the quarter. Texas Permanent School Fund Corp’s holdings in Cardinal Health were worth $5,125,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP boosted its stake in shares of Cardinal Health by 0.6% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,246,788 shares of the company’s stock worth $171,749,000 after acquiring an additional 7,940 shares in the last quarter. Raymond James Financial Inc. raised its holdings in Cardinal Health by 48.8% in the 1st quarter. Raymond James Financial Inc. now owns 567,782 shares of the company’s stock worth $78,223,000 after purchasing an additional 186,325 shares during the period. Northwest & Ethical Investments L.P. purchased a new position in Cardinal Health during the first quarter worth approximately $887,000. Brooklyn Investment Group grew its holdings in Cardinal Health by 52.1% in the first quarter. Brooklyn Investment Group now owns 931 shares of the company’s stock valued at $128,000 after purchasing an additional 319 shares during the period. Finally, Northern Trust Corp increased its position in shares of Cardinal Health by 3.5% in the first quarter. Northern Trust Corp now owns 3,143,003 shares of the company’s stock valued at $433,012,000 after buying an additional 105,154 shares in the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Trading Up 0.2%

CAH opened at $198.28 on Thursday. Cardinal Health, Inc. has a twelve month low of $115.00 and a twelve month high of $214.93. The firm has a market capitalization of $47.11 billion, a PE ratio of 29.91, a PEG ratio of 1.44 and a beta of 0.63. The firm’s 50-day moving average price is $189.29 and its 200 day moving average price is $167.65.

Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Thursday, October 30th. The company reported $2.55 EPS for the quarter, beating analysts’ consensus estimates of $2.22 by $0.33. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The company had revenue of $64.01 billion during the quarter, compared to the consensus estimate of $59.41 billion. During the same quarter in the prior year, the firm earned $1.88 EPS. Cardinal Health’s quarterly revenue was up 22.4% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be given a dividend of $0.5107 per share. The ex-dividend date is Friday, January 2nd. This represents a $2.04 dividend on an annualized basis and a yield of 1.0%. Cardinal Health’s dividend payout ratio (DPR) is presently 30.77%.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on CAH shares. TD Cowen lifted their price target on shares of Cardinal Health from $183.00 to $225.00 and gave the company a “buy” rating in a research note on Monday, November 3rd. Citigroup lifted their target price on shares of Cardinal Health from $165.00 to $190.00 and gave the company a “neutral” rating in a research report on Friday, October 31st. Jefferies Financial Group set a $220.00 target price on shares of Cardinal Health and gave the stock a “buy” rating in a research note on Monday, November 3rd. Wall Street Zen raised shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, November 8th. Finally, Wells Fargo & Company increased their target price on Cardinal Health from $185.00 to $221.00 and gave the company an “overweight” rating in a report on Wednesday, November 5th. Thirteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $209.00.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.